Matt Gagnon expressed his reluctance to discuss the White House’s recent announcement linking Tylenol consumption during pregnancy to autism, citing the entrenched beliefs on both sides of the vaccine-autism debate. He emphasized the importance of distinguishing between correlation and causation, expressing skepticism about the study’s definitiveness and its implications for autism. Despite his personal experience with Tylenol use during pregnancies, he stressed the need for careful consideration of such findings.